Speaker illustration

Professor Bjorn Knollmann

Vanderbilt University Medical Center, Nashville (United States of America)

Member of:

European Society of Cardiology

Bjorn Knollmann received a MD from the University of Cincinnati and a PhD in Pharmacology from Georgetown University. He is board-certified in Internal Medicine and Clinical Pharmacology. Bjorn Knollmann currently is Professor of Medicine and Pharmacology at Vanderbilt University School of Medicine, Nashville, Tennessee, USA. He holds the William Stokes Chair of Experimental Therapeutics and directs the Vanderbilt Center for Arrhythmia Research and Therapeutics (VanCART). He is also editor of The Goodman & Gilman’s Pharmacological Basis of Therapeutics textbook of Pharmacology. His research is focused on studying molecular mechanism and new treatments for atrial and ventricular arrhythmia and sudden cardiac death.

Cardiac myosin inhibitor MYK-581 prevents development of hypertrophic cardiomyopathy phenotype in human iPSC models

Event: ESC Congress 2025

Topic: Cardiomyopathies

Session: Molecular and immune mechanisms in cardiomyopathy

Thumbnail

Hormones and heart maturation.

Event: ESC Congress 2019

Topic: Basic Science

Session: Patient derived iPSC-modelling of inherited cardiovascular disorders

Thumbnail